Results 71 to 80 of about 2,065 (80)

Expanding the therapeutic horizon of ¹⁷⁷Lu-DOTATATE: a review of current evidence. [PDF]

Nagoya J Med Sci
Minamimoto R, Kato K, Iwano S, Nishii R, Abe Y, Naganawa S.   +5 more
europepmc   +1 more source

Transjejunal fine-needle biopsy using a forward-viewing echoendoscope for diagnosis of a rare hereditary paraganglioma. [PDF]

VideoGIE
Saito K, Kobayashi M, Yokoyama M, Taguchi T, Kimura K, Akashi T, Fujii Y, Okamoto R.   +7 more
europepmc   +1 more source

Cardiac risk in recovered Covid-19 patients evaluated by ¹²³I-mIBG. [PDF]

Sci Rep
Liebich A, Sheikh G, Bundschuh RA, Kircher M, Dierks A, Nittbaur B, Raake P, Rieger M, Higuchi T, Pfob CH, Lapa C.   +10 more
europepmc   +1 more source

Cardiac sympathetic activity and lethal arrhythmic events: insight into bell-shaped relationship between ¹²³I-meta-iodobenzylguanidine activity and event rates. [PDF]

EJNMMI Res
Nakajima K, Nakata T, Doi T, Verschure DO, Frantellizzi V, De Feo MS, Tada H, Verberne HJ.   +7 more
europepmc   +1 more source

Malignant Carotid Body Tumor in a Young Female Patient: Case Report with Review of Literature. [PDF]

Cureus
Aadil M, Haseen A, Mohammad A, Rabbani SS.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells

Nuclear Medicine Communications, 2004
A fluorine substituted derivative of meta-iodobenzylguanidine (MIBG), 4-fluoro-3-iodobenzylguanidine (FIBG), is retained in SK-N-SH human neuroblastoma cells in vitro to a higher degree than the MIBG.To investigate whether the higher retention of FIBG is due to differences in the catabolic degradation of the two tracers, in vitro paired-label studies ...
Ganesan, Vaidyanathan, Donna J, Affleck, Kevin L, Alston, Philip, Welsh, Michael R, Zalutsky   +4 more
openaire   +4 more sources

Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1986
Iodine-123-4-amino-3-iodobenzylguanidine ([123I]AIBG), an analog of 123I metaiodobenzylguanidine ([123I]MIBG), has an advantage in having a more rapid and simple synthesis. This, combined with animal data that suggested a greater affinity of the new radiopharmaceutical for the autonomic innervation of the myocardium led us to study the biodistribution ...
B L, Shulkin, B, Shapiro, M C, Tobes, S W, Shen, D M, Wieland, L J, Meyers, H T, Lee, N A, Petry, J C, Sisson, W H, Beierwaltes   +9 more
openaire   +2 more sources